Duke's AI-powered medication distribution system

Researchers at Duke University unveiled TuNa-AI, a platform that designs drug-delivery nanoparticles by fusing robotics and machine learning, which significantly increases the efficacy of cancer treatments. The specifics: Using automated lab robots, TuNa evaluated 1,275 formulations and achieved a 43% increase in successful nanoparticle manufacturing over conventional approaches. In testing, the team was able to wrap a leukemia medication that was difficult to administer in protective particles that dissolved more readily and killed more cancer cells. In a further victory, they reduced a potentially harmful component of a cancer medication by 75% while maintaining its effectiveness in mice. TuNa overcomes the constraints of current approaches that can only manage one variable by handling material selection and mixing ratios simultaneously. Many medications fail because they are unable to efficiently reach their intended targets, not because they are ineffective. AI-powered products like TuNa have the ability to revive previously discontinued medications and assist in the discovery and development of novel, safe, and efficient treatment alternatives for some of the most challenging illnesses in the world.